Intresseorganisationer
Projektets/aktivitetens namn:
Annual conference of the Melanoma Patient Network Europe Sponsorship 2023Tidplan/datum:
Startdatum: 2023-04-28Slutdatum: 2023-04-30
Läkemedelsföretag:
Novartis Sverige AB (ansvarar för innehållet i denna text)Samarbetspartner:
Melanoma Patient Network EuropeProjektbeskrivning:
After a break due to COVID, Melanoma Patient Network Europe is organizing the annual MPNE conference 28-30th of April 2023, in Brussels. MPNE2023 will have a double focus on both the latest developments in various aspects of Melanoma- treatments but also research and policy with impact or potential impact on the melanoma community; as well as concrete activities in that space. A novelty in that respect is that MPNE2023 will be testing a new interaction with the DLCT (DRUPLike Clinical Trials) community in a workshop format using a problem-based approach.Ekonomi – Belopp i SEK:
275 000Ekonomi – Beskrivning:
Total cost for this project is EURO 25 000. The objective is to support the capabilities of the EU Melanoma PAG’s. As in previous years, MPNE is seeking balanced support from different funders. Support does not entail editorial rights to conference program, faculty or any other means that could be perceived as undue influence. Supporters are encouraged to send observers and as always.Övrigt:
Kontaktpersoner:
Novartis Sverige AB, Guy Golan, +393451630584, guy.golan@novartis.comMelanoma Patient Network Europe , Bettina Ryll, +46722297272, bettina.ryll@mpneurope.com